Bruce D Gaynor
Affiliation: University of California
- Travel and implications for the elimination of trachoma in ethiopiaNeelima A Shah
Department of Public Health Sciences, University of California, Davis, California, USA
Ophthalmic Epidemiol 17:113-7. 2010..Seven hundred and seventeen households with at least one child aged 1-5 years in 48 villages were surveyed to collect the details of travel in 1 month prior to the survey...
- A rationale for continuing mass antibiotic distributions for trachomaKathryn J Ray
Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
BMC Infect Dis 7:91. 2007..Here we use mathematical models to demonstrate that repeated antibiotic distributions can eliminate infection in a reasonable time period...
- Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributionsJeremy D Keenan
F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
Invest Ophthalmol Vis Sci 53:235-40. 2012....
- Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachomaJeremy D Keenan
Department of Ophthalmology, University of California, San Francisco, CA, USA
Am J Trop Med Hyg 82:482-7. 2010....
- Effect of a single mass antibiotic distribution on the prevalence of infectious trachomaJaya D Chidambaram
F. I. Proctor Foundation, University of California, San Francisco, CA 94143-0412, USA
JAMA 295:1142-6. 2006..Repeated treatments or other effective measures will be necessary for elimination...
- Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributionsJesse B Biebesheimer
FI Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
Ophthalmology 116:2047-50. 2009..To determine whether infectious trachoma can be completely eliminated from severely affected villages...
- The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachomaSara Haug
FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California 94143 0944, USA
Clin Infect Dis 51:571-4. 2010..6% (95% CI, 18.8%-40.4%; P <.001 ) and 20.8% (95% CI, 12.7%-30.7%; P < .001), respectively. Macrolide resistance decreases after antibiotic pressure is removed...
- Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachomaJeremy D Keenan
FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
Clin Infect Dis 54:253-6. 2012..An RNA-based test detected ocular chlamydial infection in more children than did a DNA-based test (6.9% vs 4.2%), and in a larger number of communities (8 vs 7)...
- Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trialJenafir I House
FI Proctor Foundation, University of California, San Francisco, USA
Lancet 373:1111-8. 2009..We assessed indirect protection against trachoma with mass azithromycin distributions...
- Mass antibiotic treatment and community protection in trachoma control programsJaya D Chidambaram
F. I. Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA 94143-0944, USA
Clin Infect Dis 39:e95-7. 2004..Similarities with the indirect protection within a treated community (i.e., "herd protection") that has been observed in vaccination programs are discussed...
- Practice patterns and opinions in the treatment of acanthamoeba keratitisCatherine E Oldenburg
F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0944, USA
Cornea 30:1363-8. 2011..Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis...
- Childhood mortality in a cohort treated with mass azithromycin for trachomaJeremy D Keenan
F I Proctor Foundation, San Francisco, CA, USA
Clin Infect Dis 52:883-8. 2011..Here, we monitor a large cohort in which almost 90% of individuals received azithromycin. We assess whether receiving treatment is associated with reduced all-cause and infectious childhood mortality...
- Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trialAlison H Skalet
Francis I Proctor Foundation for Research in Opthalmology, University of California, San Francisco, San Francisco, California, United States of America
PLoS Med 7:e1000377. 2010..In this study, we used a randomized clinical trial design to assess whether macrolide resistance was higher in communities treated with mass azithromycin for trachoma, compared to untreated control communities...
- Rationale for mass antibiotic distribution for trachoma eliminationBruce D Gaynor
Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
Int Ophthalmol Clin 42:85-92. 2002